Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy Hikaru SasakiYohei KitamuraKazunari Yoshida Review Article 02 April 2024 Pages: 43 - 49
Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas Takuma NakashimaRyo YamamotoHiromichi Suzuki Original Article 08 February 2024 Pages: 50 - 60
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment Taketo EzakiToshihide TanakaHikaru Sasaki Original Article Open access 15 April 2024 Pages: 61 - 72
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis Takahiro TsuchiyaMasako IkemuraNobuhito Saito Original Article Open access 05 April 2024 Pages: 73 - 79
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment Fumi HiguchiTakeo UzukaKeisuke Ueki Case Report 31 January 2024 Pages: 80 - 84
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature Manabu NatsumedaSatoshi ShibumaMakoto Oishi Rapid Short communication 10 April 2024 Pages: 85 - 91
Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma Kenta MasuiHiromi OnizukaTakashi Komori Letter to the Editor 10 April 2024 Pages: 92 - 95
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next Takashi Komori Correction 25 January 2024 Pages: 96 - 96